Multiplex Assays Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2021 - 2026

Report Code: HCR 0457 Report Format: PDF + Excel (Delivery in 48 Hrs)
Multiplex Assays Market Overview 
Multiplex Assays Market size is estimated to reach $4.30bn by 2025, growing at a CAGR of 7.3% during the forecast period 2020-2025. Multiplex Assay is a type of immunoassay that uses magnetic beads to measure multiple analytes in a single experiment and is derivative of an ELISA using beads for binding the capture antibody. Increase in the adoption of companion diagnostics, growing research activities in the pharmaceutical and biotechnological industries, increase in the funding’s by governments and growing focus for enhancing the efficiency of experiments are the factors that are set to drive the growth of the global market for the forecast period 2020-2025.

Multiplex Assays Market Report Coverage
The report: “Multiplex Assays Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Multiplex Assays Market. 
By Product Type: Consumables and Instruments.
By Type: Nucleic-Based Multiplex Assay, Protein-Based Multiplex Assay and Cell-Based Multiplex Assay.
By Technology: Multiplex PCR, Flow Cytometry, Fluorescence Detection, Multiplex Microarray, Others.
By Application: Clinical Diagnostics, Research and Development, Others.
By End User: Hospitals, Pharmaceutical and Biotechnological Companies, Clinical Laboratories, Research Institutions, Others.
By Geography: North America, Asia-Pacific, Europe, and Rest of World (RoW).

Key Takeaways
  • Geographically, North America Multiplex Assays Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high demand.
  • The increase in the technology and increase in the funding’s by governments is likely to aid in the market growth of Multiplex Assays Market.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Multiplex Assays Market report.
  • The increase in the number of diseases and increase in the adoption of companion diagnostics are creating higher opportunities for the growth of market for the forecast period 2020-2025.

By Type- Segment Analysis
Based on the Type, the Nucleic-Based Multiplex Assay segment held the largest share in 2019 owing to its applications such as molecular diagnosis of human diseases, high specificity and sensitivity and ability to interrogate more than one marker simultaneously in each sample. Protein-Based Multiplex Assay segment is estimated to be the fastest growing segment during the forecast period 2020-2025. The growth in this segment is owing to its applications such as enabling researches to profile multiple analytes simultaneously and examines multiple proteins rather than having to run multiple assays to look for each protein separately.

By Technology- Segment Analysis
Based on the Technology, Flow Cytometry segment held the largest share in 2019 owing to its applications such as characterization of cell types, measurement of protein expression, quantification of intensities and sorting of predefined cells. Multiplex PCR segment is estimated to be the fastest growing segment owing to the factors such as increasing accuracy of data normalization, reduction in the input material required, cost effective and higher throughput.

By Geography - Segment Analysis 
Based on the Geography, North America held the largest share in 2019. The growth in this segment is owing to the factors such as advancements in technology, increase in the research and development activities, increase in the focus to develop novel drugs and growing patient population. Asia-Pacific is estimated to be the fastest growing segment owing to the factors such increase in the investment by the major companies in the developing nations, growing prevalence of cataract and increase in the funding by government agencies.

Drivers – Multiplex Assays Market
  • Increase in the use of TDM in anticancer therapies and technological advancements.
The increase in the use of TDM in anticancer therapies, owing to the factors such as increase in cancer patients, increasing focus on patient care and growing focus on improving efficacy and reducing toxicity is estimated to enhance the growth of Multiplex Assays Market. Advancements in technology and increase in the funding’s by the governments are also the factors which enhance the growth of Multiplex Assays Market.
  • Increasing research on the pharmaceutical and biotechnological companies and rise in the adoption of companion diagnostics.
There is an increase in the research in pharmaceutical and biotechnological companies owing to high number of diseases, well-developed infrastructures and advancements in technology. This led to rapid increase in the growth of Multiplex Assays Market. Increase in the adoption of companion diagnostics is also estimated to enhance the growth of the Multiplex Assays Market.

Challenges – Multiplex Assays Market
  • The increasing pressure on healthcare systems to provide services at low cost and complexity of clinical trial procedures.
The increasing pressure on healthcare systems to provide services at low cost is the major factor that is estimated to reduce the growth of the Multiplex Assays Market. The complexity of clinical trial procedures is also said to reduce the growth of the Multiplex Assays Market.

Multiplex Assays Industry outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Multiplex Assays Market. Key companies of this market are Agilent Technologies, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, QIAGEN, Randox Laboratories Ltd, Illumina Inc, Meso Scale Diagnostics LLC, Luminex Corporation, Sysmex Corporation, Bio-Techne, among others.

Acquisitions/Product Launches:
  • In 2018, QIAGEN has entered into agreement to acquire STAT-Dx for developing the next generation of multiplex assay diagnostics for fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology. 
  • In 2020, Luminex Corporation has launched MAGPIX multiplexing assay, an analytical instrument that is capable of performing 50 tests on a single sample and is designed to meet the needs of academic researchers and scientists to take the advantage of the power of multiplexing.
1. Multiplex Assays Market - Overview
    1.1 Definitions and Scope
2. Multiplex Assays Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Technology
    2.4 Key trends by Application
    2.5 Key trends by End User
    2.6 Key trends by Geography
3. Multiplex Assays Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies 
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Multiplex Assays Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Multiplex Assays Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Multiplex Assays - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Multiplex Assays Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Multiplex Assays Market – By Product Type (Market Size – $Million/$Billion)
    8.1 Consumables
    8.2 Accessories
9. Multiplex Assays Market – By Type (Market Size – $Million/$Billion)
    9.1 Nucleic-Based Multiplex Assay
    9.2 Protein-Based Multiplex Assay
    9.3 Cell-Based Multiplex Assay
10. Multiplex Assays Market – By Technology (Market Size – $Million/$Billion)
    10.1 Multiplex PCR
    10.2 Flow Cytometry
    10.3 Fluorescence Detection
    10.4 Multiplex Microarray
    10.5 Others
11. Multiplex Assays Market – By Application (Market Size – $Million/$Billion)
    11.1 Clinical Diagnostics
    11.2 Research and Development
    11.3 Others
12. Multiplex Assays Market – By End User (Market Size – $Million/$Billion)
    12.1 Hospitals
    12.2 Pharmaceutical and Biotechnological Companies
    12.3 Clinical Laboratories
    12.4 Research Institutions
    12.5 Others
13. Multiplex Assays Market - By Geography (Market Size – $Million/$Billion)
    13.1 North America
        13.1.1 U.S.
        13.1.2 Canada
        13.1.3 Mexico
    13.2 Europe
        13.2.1 U.K.
        13.2.2 Germany
        13.2.3 France
        13.2.4 Italy
        13.2.5 Spain
        13.2.6 Rest of Europe
    13.3 Asia-Pacific
        13.3.1 China
        13.3.2 India
        13.3.3 Japan
        13.3.4 South Korea
        13.3.5 Australia & New Zealand
        13.3.6 Rest of Asia-Pacific
    13.4 Rest of the World
        13.4.1 Middle East
        13.4.2 Africa
        13.4.3 South America
14. Multiplex Assays Market - Entropy
15. Multiplex Assays Market – Industry/Segment Competition Landscape Premium 
    15.1 Market Share Analysis
        15.1.1 Global Market Share – Key Companies
        15.1.2 Market Share by Region – Key companies
        15.1.3 Market Share by Countries – Key Companies
        15.1.4 Best Practices for Companies
16. Multiplex Assays Market – Key Company List by Country Premium Premium
17. Multiplex Assays Market Company Analysis
    17.1 Company 1
    17.2 Company 2
    17.3 Company 3
    17.4 Company 4
    17.5 Company 5
    17.6 Company 6
    17.7 Company 7
    17.8 Company 8
    17.9 Company 9
    17.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.